A Stepped Care Model of Adolescent Depression Treatment in Primary Care



Status:Completed
Conditions:Depression, Major Depression Disorder (MDD), Endocrine
Therapuetic Areas:Endocrinology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases
Healthy:No
Age Range:13 - 20
Updated:11/8/2014
Start Date:September 2011
End Date:July 2014
Contact:Laura Mufson, PhD
Email:MufsonL@nyspi.columbia.edu
Phone:212-543-5561

Use our guide to learn which trials are right for you!

It is challenging for depressed adolescents and their families to access specialized mental
health services. A viable option is delivering treatment in the primary care clinic (PCC)
setting; however, few effective models are currently available. The overall aim of this
study is to assess in the pediatric PCC, the preliminary acceptability and feasibility of a
novel collaborative stepped care model of treatment for depressed adolescents.

Interpersonal Psychotherapy for adolescents (IPT-A) is a guideline based treatment with
established efficacy focusing on reducing depression symptoms and current interpersonal
problems associated with depression. This stepped care model (SCIPT-A) first delivers a low
intensity 6 session plus two parent session adaptation of IPT-A, a treatment designed for
mild to moderate adolescent depression with impairment. The second phase in the model is for
adolescents with persistent depressive symptoms who will receive 8 more sessions of IPT-A in
combination with the addition of an antidepressant. The social worker clinicians (SW)
currently employed in the PCC will be trained to deliver the Brief Interpersonal
Psychotherapy for adolescents (BIPT-A)and in the second phase, the pediatrician will provide
the medication treatment in collaboration with the SW clinician continuing to provide IPT-A.
Fifty adolescents identified by their primary care pediatrician and meeting criteria for
DSM-IV major depression, dysthymic disorder, or depression, not otherwise specified will be
randomized to receive either treatment as usual (TAU) or the SCIPT-A model of stepped
collaborative depression care in the PCC for 16 weeks. TAU consists of pediatrician referral
of depressed adolescents to either a psychologist, social worker or child psychiatrist
within the clinic or to another mental health agency in the community. All adolescents will
be administered clinical interviews and self-report questionnaires during the 16 week
protocol to assess treatment acceptability, feasibility, safety and preliminary change in
symptoms. The project will provide information concerning the feasibility and acceptability
of this treatment model for adolescent depression delivered by pediatricians and social work
clinicians in pediatric primary care practice.

Inclusion Criteria:

- Males and females ages 13-20 years

- English and Spanish speaking adolescent

- Parent may be monolingual or bilingual in Spanish

- DSM-IV diagnosis of Major Depressive Disorder, dysthymia, or Depressive Disorder Not
Otherwise Specified

- Moderate impairment in functioning

- Moderate depression severity

- Willing to refrain from other medications unless provided by investigator or PCP
during the study

Exclusion Criteria:

- Diagnoses of Post Traumatic Stress Disorder , Obsessive Compulsive Disorder, current
Substance abuse, Schizophrenia, bipolar disorder, Conduct disorder, Active eating
disorder, Pervasive Developmental Disorder, Autism, Asberger's, Psychosis

- Engagement in severe self-injurious behavior in past 3 months

- Active suicidal ideation with plan or intent

- Mental retardation or severe learning disability

- Medical illness that may interfere with treatment

- Open Administration for Children's Services (ACS) case

- Pregnancy

- Already receiving psychotherapy or medication treatment for depression or have begun
a medication trial for another diagnosis within the previous three months

- History of intolerance to fluoxetine or escitalopram

- Failed 2 completely adequate and documented Antidepressant trials

- Co-morbid Attention Deficit Hyperactivity Disorder if not on stable dose of
stimulants
We found this trial at
1
site
1051 Riverside Dr
New York, New York 10032
646-774-5000
New York State Psychiatric Institute The New York State Psychiatric Institute (NYSPI), established in 1895,...
?
mi
from
New York, NY
Click here to add this to my saved trials